Novartis' Operating Profit Fell 14% in the First Quarter, to us$4.9 Billion.

Le Temps

Lean Left

Factuality

Ownership

The decrease in the results of the Basel giant, linked to the competition of generic medicines in the US market, was expected. But the figures published this Wednesday proved to be below expectations. The group nevertheless maintains its financial targetsDuring the presentation of its annual results in February, Novartis warned that it expected a more complicated year 2026. Unsurprisingly, this Tuesday, the Basel giant published results in retre…

Globo

Lean Right

Factuality

Ownership

For 2026, the company continues to forecast single-digit sales growth, while core operating profit is expected to decline in the same range.

Schweizer Radio und Fernsehen (SRF)

Lean Left

Factuality

Ownership

The Basel-based pharmaceutical company was challenged by imitation products for some important medicines.